BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 31462429)

  • 21. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 22. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1.
    Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL
    Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
    Guo J; Jia J; Jia R
    Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
    Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
    RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression.
    Hua D; Zhao Q; Yu Y; Yu H; Yu L; Zhou X; Wang Q; Sun C; Shi C; Luo W; Jiang Z; Wang W; Wang L; Zhang D; Tang S; Yu S
    Eur J Pharmacol; 2021 Jan; 890():173669. PubMed ID: 33098832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
    Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
    Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.
    Voss DM; Sloan A; Spina R; Ames HM; Bar EE
    Cancer Res; 2020 Nov; 80(21):4681-4692. PubMed ID: 32928918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
    Che Y; Bai M; Lu K; Fu L
    Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.
    Ding Y; Herman JA; Toledo CM; Lang JM; Corrin P; Girard EJ; Basom R; Delrow JJ; Olson JM; Paddison PJ
    Oncotarget; 2017 Jul; 8(30):48545-48562. PubMed ID: 28596487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
    Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
    Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
    Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
    Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-H3 is spliced by SRSF3 in colorectal cancer.
    Zhang C; Chen Y; Li F; Yang M; Meng F; Zhang Y; Chen W; Wang W
    Cancer Immunol Immunother; 2021 Feb; 70(2):311-321. PubMed ID: 32719950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
    Ajiro M; Tang S; Doorbar J; Zheng ZM
    J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.
    Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y
    Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
    Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
    Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.
    Zhou X; Li X; Yu L; Wang R; Hua D; Shi C; Sun C; Luo W; Rao C; Jiang Z; Wang Q; Yu S
    Int J Biochem Cell Biol; 2019 Aug; 113():75-86. PubMed ID: 31200124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.
    Mao XG; Hütt-Cabezas M; Orr BA; Weingart M; Taylor I; Rajan AK; Odia Y; Kahlert U; Maciaczyk J; Nikkhah G; Eberhart CG; Raabe EH
    Oncotarget; 2013 Jul; 4(7):1050-64. PubMed ID: 23846349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.